Write a reviewFor vendors
♡
Home / Investors / Sebastian Kreuz

Sebastian Kreuz

Corporate VC · Ingelheim am Rhein

About Sebastian Kreuz

Corporate venture investor (Head of Boehringer Ingelheim Venture Fund EU) based in Ingelheim am Rhein, Germany. Focus areas include Health Care, Research and Development, Hospitals. Invests at series b, series a stage. Past investments include Aignostics, T3 Pharmaceuticals, Dopavision.

Investment focus

Stages
Series BSeries A
Sectors
Health CareResearch and DevelopmentHospitalsWellnessWomen FoundedHealthcare InnovationChemicalLife ScienceArtificial Intelligence (AI)SoftwareManufacturingBiotechnologyDrug DevelopmentCosmeticsMarket ResearchInnovationResearchHealth DiagnosticsInnovation ManagementDigital Health

Portfolio

No portfolio companies recorded yet; Sebastian Kreuz reports 39 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits